Miguel López

Miguel is the Founder of Xana. He holds a Doctorate in Psychopharmacology from the Complutense University of Madrid with research experience studying the neurobiological bases of Post-Traumatic Stress Disorder, Professor under Prof. Carmen Sandi team, Brain Mind Institute, Lausanne, EPFL, Switzerland. In addition, over 10 years of experience as a consultant and entrepreneur within the medical technology industry.